PHARMACY

McKesson improves patient outreach with new call center

BY Michael Johnsen

SCOTTSDALE, Ariz. — McKesson Patient Relationship Solutions, a division of McKesson Corporation, on Tuesday announced the expansion of its patient engagement and support capabilities with a second Contact Center near Atlanta, Ga. The new location builds on the capabilities of MPRS’ existing Contact Center at its headquarters in Scottsdale, Ariz. 
 
The expansion is designed to accommodate significant growth in demand for its Behavioral Call Campaign offering, which leverages interactive behavioral conversations with patients to help increase engagement and improve medication adherence. The expansion also supports growth in MPRS’ core co-pay savings programs as well as new innovative platforms to further advance patient adherence.
 
“This expansion is a direct result of the increasing need for our pharmaceutical and medical device manufacturer clients to uniquely connect with their patients through both inbound and outbound conversations to support patient needs,” said Jennifer Richard, director of contact center operations at MPRS. “Our continued growth allows us to leverage our expertise to consistently deliver award-winning customer service to our existing clients. In addition, it supports the implementation of innovative new campaigns that incorporate proven and sustainable patient engagement tactics that deliver positive ROI.”
 
Traditional call centers have primarily provided responses to simple questions from patients about their medications; however, the ability to create lasting behavior change was limited. Recent research commissioned by MPRS showed that patients are less interested in receiving general information about their condition and more interested in personalized communications. Specifically, 86% of patients desired live agent phone support and 83% desired face-to-face pharmacist coaching and support. With dynamic, two-way conversations, McKesson’s Contact Center agents have successfully delivered personalized and targeted messaging that improved the patient experience, medication adherence, and ultimately health outcomes.
 
“The significant growth of our Contact Center capabilities this year demonstrates that pharmaceutical and medical device brands increasingly value a two-way dialogue that is integrated with their patient support strategy,” said Derek Rago, VP/general manager, MPRS. “Leveraging both our co-pay support programs and our proven behavioral coaching platform provides our clients with an integrated brand experience and allows us to support the patient holistically, addressing behavioral as well as cost-related barriers to adherence.”
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

APhA accepting annual awards, honors program nominations

BY Antoinette Alexander

WASHINGTON — Nominations are now being accepted for the American Pharmacists Association annual awards and honors program. The awards will be presented at the APhA Annual Meeting and Exposition in Baltimore from March 4 to 7, 2016.

American Pharmacists Association – Profession Wide Awards:

  • Remington Honor Medal: the pharmacy profession’s highest honor, recognizes distinguished service on behalf of American pharmacy during the preceding year, culminating in the past year, or during a long period of outstanding activity or fruitful achievement.
  • Community Pharmacy Residency Excellence in Precepting Award: recognizes a community pharmacy residency director or preceptor who has demonstrated excellence in precepting, mentoring, leadership and community pharmacy residency program administration.
  • Distinguished Federal Pharmacist Award: recognizes a pharmacist who has distinguished himself or herself and the profession through outstanding contributions in federal pharmacy practice, resulting in significant improvement in the health of the nation and/or the population he or she serves.
  • Distinguished New Practitioner Award: recognizes an APhA member, within his/her first five years after graduation, who has demonstrated distinctive achievements in mentorship, service and commitment to the profession of pharmacy.
  • Generation Rx Award of Excellence: recognizes an APhA member pharmacist who has demonstrated a commitment to substance abuse education.
  • Gloria Niemeyer Francke Leadership Mentor Award: recognizes an individual who has promoted and encouraged pharmacists to attain leadership positions within pharmacy through example as a role model and mentor.
  • Good Government Pharmacist-of-the-Year Award: recognizes an individual pharmacist who actively contributes to the community through his or her involvement in the political process.
  • Honorary Membership: conferred upon individuals, either within or outside the pharmacy profession, whose activities and achievements have had a significant impact upon public health, the profession and its practitioners.
  • Honorary President: conferred by the Association upon a member who has made significant contributions to the Association.
  • Hugo H. Schaefer Award: recognizes APhA members who have made outstanding voluntary contributions to society, the profession of pharmacy and APhA.
  • Hubert H. Humphrey Award: recognizes APhA members who have made major contributions in government and/or legislative service at the local, state or national level.
  • American Pharmacists Association – Academy of Pharmacy Practice and Management (APhA-APPM):
  • Daniel B. Smith Practice Excellence Award: recognizes an APhA member, in any practice setting, who has distinguished himself or herself and the profession of pharmacy by sustained outstanding performance and achievement.
  • APhA-APPM Pharmacy Management Excellence Award: recognizes an APhA member in any practice setting who has distinguished himself/herself and the profession by outstanding performance in the area of pharmacy management.
  • APhA-APPM Distinguished Achievement Awards: recognize individuals who have made a significant or sustained contribution to pharmacy practice and have advanced the missions of APhA and APhA-APPM.
  • Distinguished Achievement in Pharmacy Practice
  • Distinguished Achievement in Pharmacy Management
  • Distinguished Achievement in Service
  • APhA-APPM William H. Briner Distinguished Achievement Award in Nuclear Pharmacy Practice: recognizes significant or sustained contributions to nuclear pharmacy practice.

American Pharmacists Association – Academy of Pharmaceutical Research and Science (APhA-APRS):

•    Research Achievement Award in the Pharmaceutical Sciences: recognizes outstanding, meritorious achievement in any of the pharmaceutical sciences. In 2016, the award will recognize contributions in the area of basic sciences.

Fellows of the American Pharmacists Association:
Fellows are either members of the APhA Academy of Pharmacy Practice and Management (APhA-APPM) or the APhA Academy of Pharmaceutical Research and Science (APhA-APRS) with a minimum of 10 years professional experience. To become a Fellow, members must have demonstrated exemplary professional achievements and service to the profession through activities with APhA and other national, state or local professional organizations.

Guidelines for nominations and complete criteria for each award are available at pharmacist.com/awards. Nominations are due no later than Sept. 1 (Honorary President: Oct. 15).

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

Report: Sandoz fights to bring first biosimilar to U.S.

BY Michael Johnsen

SAN FRANCISCO — Sandoz argued before the U.S Court of Appeals for the Federal Circuit Wednesday in an effort to lift a preliminary injunction barring the sale of its Zarxio biosimilar medicine, Reuters reported
 
Amgen, the maker of Neupogen, sued to have Zarxio barred from the market this past fall for patent infringement. 
 
According to Reuters, if the injunction were to be lifted, Zarxio would become the first biosimilar sold in the United States.
 
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?